article thumbnail

Report: Primary Care Physicians Are Addressing Mental Health Concerns More Frequently

MedCity News

The Health Affairs study found that in 2006, 10.7% of primary care visits addressed mental health concerns, compared 15.9% by 2016 and 2018, representing a 50% increase.

article thumbnail

From neurosurgery to focused ultrasound: Not if, but when

pharmaphorum

In today’s podcast, web editor Nicole Raleigh speaks with Dr Neal Kassell, chair and founder of the Focused Ultrasound Foundation and previously a neurosurgeon, who created the Foundation in 2006 to improve the lives of millions of people with serious medical disorders by accelerating the development and adoption of focused ultrasound.

Medical 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The perfect storm is coming for pharma

World of DTC Marketing

Retail price increases for widely used brand name prescription drugs consistently exceeded the rate of general inflation between 2006 and 2020. SUMMARY: One area where Republicans and Democrats agree is that drug pricing is out of control. In contrast, the general inflation rate was 1.3 percent over the same period. percent.

Pharma 195
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance). Amsterdam: Gupta Strategists; 2019.

article thumbnail

Sandoz to file for approval of aflibercept biosimilar

European Pharmaceutical Review

Sandoz launched its first biosimilar – somatropin (Omnitrope) – in Europe in 2006. The company, a division of Novartis, currently has a portfolio of eight marketed biosimilars, with a further 24 in various development stages.

Safety 98
article thumbnail

Gilead wins patent battle with US government over HIV PrEP drugs

Pharmaceutical Technology

The CDC had applied for patents back in 2006, and was later granted four in 2015. The government had called for Gilead to “respect the US patent system” and the taxpayer-funded research undertaken by the CDC, per the statement. The November 2019 lawsuit marked a further escalation in an existing dispute.

article thumbnail

Drug pricing increases are disgraceful

World of DTC Marketing

In November 2017, a study published in JAMA Internal Medicine examined the costs of developing 10 cancer drugs approved by the FDA from 2006 to 2015 and provided a strong contrast to the Tufts study from a year before.

Insurance 198